London’s cocoa market blighted by ‘poisoned pill’

  • 📰 FT
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

Poorer quality stock in UK warehouses has led to a rare divergence in prices with the New York market

A frantic hunt by chocolate manufacturers for high-grade cocoa has left a backlog of old, poor-quality beans lying in London’s warehouses, leading to a rare divergence in prices between the UK and the US. Last month cocoa futures traded in New York rose strongly, peaking above $10,000 last week, while London prices fell, dipping below $6,400 earlier this month.

These new rules oblige traders and chocolate companies to prove that the cocoa they import into the EU was not grown on deforested land. Some industry traders and executives had hoped the incoming rules would allow the lower-grade material to be written off as unusable. But the EU allowed older, existing stocks to be “grandfathered” into the bloc — meaning they could still be bought and sold.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 113. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Pharma companies' strategies for reaching poorer countries remain unclearPharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these efforts, says Jayasree Iyer, CEO of the Access to Medicine Foundation.
La source: NewsMedical - 🏆 19. / 71 Lire la suite »

Pharma companies' strategies for reaching poorer countries remain unclearPharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these efforts, says Jayasree Iyer, CEO of the Access to Medicine Foundation.
La source: NewsMedical - 🏆 19. / 71 Lire la suite »